President Trump's 2026 budget proposes cutting NIH grants to universities, academic medical centers, and other institutions ...

Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and ...

From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic ...

The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.

It looks like the NIH is thinking about AI differently than the FDA, who earlier this week released a “rushed” AI tool across ...

Omada Health, a digital health company for 14 years supporting chronic disease patients, is yet to generate profits.

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...

His admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this administration.

WASHINGTON — President Trump declared Medicare off-limits several months ago, but Republicans are now considering ways to ...

An Otsuka drug succeeded in a Phase 3 study in a chronic kidney disease, with results that outperformed a competitor's recent ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...